Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to -$348000.0.

  • Harvard Bioscience's Cash from Investing Activities rose 6867.69% to -$348000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year increase of 1077.88%. This contributed to the annual value of -$1.3 million for FY2024, which is 2529.18% up from last year.
  • Latest data reveals that Harvard Bioscience reported Cash from Investing Activities of -$348000.0 as of Q3 2025, which was up 6867.69% from -$233000.0 recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Cash from Investing Activities registered a high of $458000.0 during Q2 2024, and its lowest value of -$1.1 million during Q3 2024.
  • Its 5-year average for Cash from Investing Activities is -$386421.1, with a median of -$401000.0 in 2023.
  • In the last 5 years, Harvard Bioscience's Cash from Investing Activities plummeted by 35148.94% in 2023 and then skyrocketed by 17328.0% in 2024.
  • Over the past 5 years, Harvard Bioscience's Cash from Investing Activities (Quarter) stood at -$358000.0 in 2021, then surged by 34.36% to -$235000.0 in 2022, then crashed by 351.49% to -$1.1 million in 2023, then skyrocketed by 56.08% to -$466000.0 in 2024, then grew by 25.32% to -$348000.0 in 2025.
  • Its Cash from Investing Activities was -$348000.0 in Q3 2025, compared to -$233000.0 in Q2 2025 and -$683000.0 in Q1 2025.